{"id":3101,"date":"2021-12-13T06:07:02","date_gmt":"2021-12-13T06:07:02","guid":{"rendered":"https:\/\/mgt.sjp.ac.lk\/vjm\/?post_type=journal_article&p=3101"},"modified":"2021-12-13T06:54:29","modified_gmt":"2021-12-13T06:54:29","slug":"making-intellectual-property-a-common-good-to-combat-global-pandemics-and-the-covid-19-technology-access-pool-c-tap-responding-the-challenges-exerted-by-big-pharma-and-some-high-income-countries","status":"publish","type":"journal_article","link":"https:\/\/mgt.sjp.ac.lk\/vjm\/journal_article\/making-intellectual-property-a-common-good-to-combat-global-pandemics-and-the-covid-19-technology-access-pool-c-tap-responding-the-challenges-exerted-by-big-pharma-and-some-high-income-countries\/","title":{"rendered":"Making Intellectual Property a Common Good to Combat Global Pandemics and the COVID-19 Technology Access Pool (C-TAP): Responding the Challenges Exerted by Big Pharma and Some High-Income Countries"},"content":{"rendered":"

<\/p>\n

\n

\n

A.A.C.J Adikari and Sanath Sameera Wijesinghe<\/p>\n


<\/b><\/p>\n

Abstract <\/b><\/p>\n

The COVID-19 outbreak has created a global race for research into a vaccine, diagnostic and therapeutic among research institutes, governments, and big-tech pharmaceutical companies (Big Pharma). In this context, intellectual property rights (IPRs) play a prominent role in incentivizing COVID-19 vaccines. Simultaneously, IPRs, particularly the patent rights of Big Pharma, create restrictions on fair access to affordable COVID-19 vaccines. Besides, economically powerful high-income countries have purchased and reserved a large amount of COVID 19 vaccines while low and middle-income countries (LMICs) have been struggling to obtain sufficient vaccine doses. These factors have contributed to increasing the gap of access to affordable COVID-19 vaccines between high-income countries and LMICs. Having foreseen the likely effect of LMICs being discriminated against in the global COVID-19 vaccine production and distribution, the global community has already made some efforts to revisit the normative aspects of IPRs by making intellectual property a common good to achieve global health during the pandemic. For example, the World Health Organization (WHO) has launched the COVID-19 Technology Access Pool (C-TAP), considering the proposal made by Costa Rica. The C-TAP intended to ensure technology transfer, disclosure of research, flexible licensing and open innovations. However, Big Pharma and some high-income countries have criticised and directly interfered in the effective functioning of C-TAP. Therefore, there remains a question as to whether the C-TAP approach would only be idealistic or realistic in the global governance of IPRs and public health. Accordingly, this paper critically analyses the prospects that C-TAP would offer LMICs to overcome IPRs-related barriers and resource constraints in accessing the COVID-19 vaccine and reflect on how to tackle Big Pharma and some high-income countries\u2019 influences on the effective functioning of C-TAP.\u00a0<\/span><\/p>\n

\n<\/div><\/div><\/div><\/div><\/div><\/section>

<\/p>\n

Key words: <\/span><\/b><\/p>\n

Access to medicine, Big Pharma, COVID-19 vaccine, C-TAP, IP as a common good<\/o:p><\/span><\/p>\n

\n<\/div><\/div><\/div><\/div><\/div><\/section>

<\/div><\/div><\/div><\/div><\/div><\/section>
<\/p>\n

Download<\/b><\/p>\n

\n<\/div><\/div><\/div><\/div><\/div><\/section>

\n\t\t\n\t\t<\/i>\n\t\t<\/a>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div><\/div><\/div><\/section>
<\/p>\n

Cite this paper:<\/span><\/p>\n

A.A.C.J Adikari<\/span> and <\/span>Sanath Sameera Wijesinghe. (2021). <\/span>Making Intellectual Property a Common Good to Combat Global Pandemics and the COVID-19 Technology Access Pool (C-TAP): Responding the Challenges Exerted by Big Pharma and Some High-Income Countries, <\/span>Vidyodaya<\/span> Journal<\/span> of Management,7(2), <\/span>69-99.\u00a0<\/span><\/p>\n

DOI:\u00a0<\/span>https:\/\/doi.org\/10.31357\/vjm.v7iII.5096<\/span><\/a><\/p>\n

\n<\/div><\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"author":2,"template":"","journal_article_cats":[213],"_links":{"self":[{"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/journal_article\/3101"}],"collection":[{"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/types\/journal_article"}],"author":[{"embeddable":true,"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/media?parent=3101"}],"wp:term":[{"taxonomy":"journal_article_cat","embeddable":true,"href":"https:\/\/mgt.sjp.ac.lk\/vjm\/wp-json\/wp\/v2\/journal_article_cats?post=3101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}